Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Myriad Genetics Inc (NASDAQ:MYGN)

33.32
Delayed Data
As of Jul 29
 -0.38 / -1.13%
Today’s Change
31.34
Today|||52-Week Range
39.95
-2.17%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues402.1M496.0M613.2M778.2M
 
 
 
 
 
Cost of Goods Sold39.5M55.6M70.7M95.4M
 
 
 
 
 
Depreciation And Amortization7.2M9.1M8.9M13.8M
 
 
 
 
 
 
Operating ExpensesGross Income355.4M431.3M533.5M669.0M
 
 
 
 
 
General Expenses197.6M251.0M304.1M394.6M
 
 
 
 
 
Research And Development27.8M42.6M52.2M67.5M
 
 
 
 
 
Total Operating Expenses244.3M315.7M383.7M503.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income157.8M180.3M229.5M274.4M
 
 
 
 
 
Extraordinary Charge0.000.00-1.5M0.00
 
 
Other Expenses-353.0K-407.0K-223.0K-2.0M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income159.7M184.5M233.3M277.9M
 
 
 
 
 
Income Taxes-58.9M-72.4M-86.1M-101.6M
 
 
 
 
 
Net Income100.7M112.2M147.1M176.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS89.8M84.6M80.9M75.7M
 
 
 
 
 
Shares To Calculate EPS Diluted91.7M86.5M83.3M78.2M
 
 
 
 
 
 
Earnings Per ShareEPS$1.10$1.30$1.77$2.25
 
 
 
 
 
EPS Diluted$1.10$1.30$1.77$2.25